P-342: Early-onset diabetes mellitus as the inaugural manifestation of STAT1 gain-of-function mutation (IMD31C): a case report
Hormone Research in Paediatrics · 04.11.2026 · 99 (Supplement_4)
DOI: 10.1159/hrp/adaag020.400 ↗Kurz gefasst
Fallbericht in der Zeitschrift Hormone Research in Paediatrics, online erschienen am 04.11.2026. Verfasst von A Coelho und 3 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction
Immunodeficiency 31C (IMD31C), caused by heterozygous STAT1 gain-of-function (GOF) mutations, classically presents with chronic mucocutaneous candidiasis (CMC), autoimmune disorders and recurrent infections. Diabetes mellitus has been reported as a late feature, typically after candidiasis onset. Early-onset diabetes as the inaugural IMD31C manifestation has not been previously described.
Objectives
To report an atypical IMD31C presentation in which neonatal-onset diabetes mellitus preceded candidiasis and preceded molecular diagnosis.
Methods
Retrospective case report of a male patient at a pediatric referral center. Genetic workup included monogenic diabetes panel, MS-MLPA for neonatal diabetes and whole-exome sequencing (WES), all performed in 2025.
Results
A 2-year-10-month-old boy developed polydipsia, polyuria, weight loss and chronic diarrhea at age 3 months, presenting with diabetic ketoacidosis. Neonatal diabetes was suspected; sulfonylurea trial failed and insulin (basal-bolus, later CSII) was maintained. Candidiasis appeared concomitantly. At 14 months, hypochromic microcytic anemia was treated with iron. At 2 years, recurrent candidiasis prompted immunological evaluation: hypogammaglobulinemia (low IgG, IgA, IgM) and altered CD19; two IVIG infusions were given. Monogenic panel and MS-MLPA were normal. WES identified heterozygous STAT1 c.1398C>A (p.Ser466Arg), confirming IMD31C.
Conclusions
This case expands the IMD31C phenotypic spectrum: early-onset diabetes preceded candidiasis as the inaugural manifestation, a presentation not previously described. STAT1 GOF mutations should be considered in infants with unexplained early-onset diabetes associated with chronic diarrhea or immune dysregulation, even before candidiasis appears.
Zitieren
APA
Coelho, A., Ramos, T., Cudizio, L., & Calliari, L. E. (2026). P-342: Early-onset diabetes mellitus as the inaugural manifestation of STAT1 gain-of-function mutation (IMD31C): a case report. Hormone Research in Paediatrics, 99(Supplement_4). https://doi.org/10.1159/hrp/adaag020.400
Vancouver
Coelho A, Ramos T, Cudizio L, Calliari LE. P-342: Early-onset diabetes mellitus as the inaugural manifestation of STAT1 gain-of-function mutation (IMD31C): a case report. Hormone Research in Paediatrics. 2026;99(Supplement_4). doi:10.1159/hrp/adaag020.400
BibTeX
@article{Coelho2026,
author = {Coelho, A and Ramos, T and Cudizio, L and Calliari, L E},
title = {P-342: Early-onset diabetes mellitus as the inaugural manifestation of STAT1 gain-of-function mutation (IMD31C): a case report},
journal = {Hormone Research in Paediatrics},
year = {2026},
volume = {99},
number = {Supplement_4},
doi = {10.1159/hrp/adaag020.400}
}
EUVIMED